✨ Your Portfolio is fetched and updated from zerodha.
Small Insurance
Market Cap
₹15,091 Cr.
P/E
83.82

Key Ratios

Market cap
Market cap
15,091 Cr
PE
PE
83.82
Prom Holding
Prom Holding
55.98 %
ROE (%)
ROE (%)
8.36
ROCE (%)
ROCE (%)
7.62
Div Yield (%)
Div Yield (%)
-
Sales
Sales
-
OPM (%)
OPM (%)
-
Debt to Equity
Debt to Equity
-
About
Niva Bupa Health Insurance is a leading standalone health insurer in India, specializing in th… Read more
Low
69
52W Range
High
109
  • Niva Bupa Health Ins
  • Star Health & Allied
  • New India Assurance
  • TJI Insurance

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Market Share
1.86 %
(as of May 25)
Gross Direct Premium Income - Market Share
4.44 %
(as of May 25)
Health Insurance - Market Share
Revenue mix

Product Wise Break-Up - Premium wise

Location Wise Break-Up

Distribution Channel

Operating Profit Break-Up

Operational Metrics

    Select a Metric
    • Yield On Total Investments - General Insurance (%)
    • Combined Ratio (%)
    • Monthly Gross Direct Premium Income (GDPI) (Crs)
    • Risk Retention Ratio (%)
    • Claim Settlement Ratio (%)
    Peer Comparison
    FAQs on Niva Bupa Health Insurance Company Ltd. Business

    Niva Bupa Health Insurance is a standalone health insurer (SAHI) strategically focused on the retail health market. The company is one of India’s largest and fastest growing SAHIs. It also offers personal accident and travel insurance products to its customers. Its purpose is to ‘give every Indian the confidence to access the best healthcare’.

    Niva Bupa Health Ins major competitors are IIFL Capital Service, Kelvin Fincap, Arihant Multi Comml., Dee Kartavya Fin., Golden Legand Lease, Shreekrishna Biotech, Oasis Nutraceuticals.
    Market Cap of Niva Bupa Health Ins is ₹13,273 Crs.
    While the median market cap of its peers are ₹217 Crs.

    Niva Bupa Health Ins seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release May
    Investor Presentation May Sep Dec
    Conference Call Mar Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material